John Andrew Goodman Levy

CBRE, Inc. engages in the provision of commercial real estate brokerage solutions. The company offers services relating to advisory, workplace solutions, and real estate investments. It also provides real estate services for investors and occupiers. The company is headquartered in Los Angeles, CA.

The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs.

University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA.

The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023.

Part of Sanofi, Aventis Bio-Services, Inc. develops pharmaceutical and agricultural products. The company is based in King of Prussia, PA.

SAFC Biosciences, Inc. develops, manufactures, markets cell culture reagents and services targeted for commercial firms involved in developing and producing biopharmaceuticals using mammalian and insect cell culture methods. The company was acquired in 2005 by chemical supplier Sigma Aldrich Corp. The company was founded in 1971 and is headquartered in Lenexa, KA

Part of Novartis AG, Seqirus Vaccines Holdings Ltd. is a British company that functions as an investment holding company. The company is based in Maidenhead, UK and was founded in 2003.

Kedrion SpA is a holding company, which engages in the production and distribution of plasma-derived therapeutic products for the treatment of hemophilia and immune system deficiencies. It offers standard intravenous immunoglobulin, human albumin solution, human rabies immunoglobulin, prothrombin complex concentrate, and fibrin sealant. Its products include Kedrab, Gammaked, Uman Complex, Kolfib, and Uman Albumin. The company was founded by Guelfo Marcucci in 2001 and is headquartered in Barga, Italy.

CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA.

CSL Plasma, Inc. collects donations of blood plasma in the U.S. through donation centers. The plasma is used by the company's parent to manufacture hemophilia therapies, burns, shock, infection, trauma, and breathing disorders. The company was founded in 2004 and is headquartered in Boca Raton, FL.

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

CSL Behring NV engages in the research and development of biotherapies for the treatment of rare and severe illnesses. It offers hematology, immunology, pneumology and specific medicine. The company was founded on February 15, 1995 and is headquartered in Mechelen, Belgium.

Part of CSL Ltd., CSL Behring UK Ltd. is a company that manufactures and supplies plasma therapies. The company is based in Haywards Heath, UK. The British company was founded in 1916 by Emil von Behring.

Part of CSL Ltd., CSL Behring GmbH is a German company that actively collaborates to develop special programs and activities for patients with rare diseases. The company is based in Marburg, Germany. The CEOs of the company are Lutz Guenter Bonacker, Michael Schröder, Craig Shelanskey.

CSL Behring AB develops, manufactures, and markets protein-based therapies in the bleeding disorders, critical care, immunoglobulins, and pulmonary areas. It offers therapies such as plasma-derived and recombinant coagulation factors, immunoglobulins for the treatment of primary immune deficiency, alpha1-proteinase inhibitor for chronic A1-PI augmentation therapy, and C1-INH concentrate. The company was founded in 1904 and is headquartered in Danderyd, Sweden.

Wuhan Zhongyuan Ruide Biological Products Co., Ltd. engages in the research and development, manufacture, and sale of biological products and blood products. The company was founded on on June 11, 2010 and is headquartered in Wuhan, China.

Kedrion Biopharma, Inc. operates as an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing diseases, disorders and conditions such as hemophilia, primary immune system deficiencies and Rh-sensitization. Its services include Italian partnership, contract manufacturing, technology transfer, and biological safety center. The company was founded in 2011 and is headquartered in Fort Lee, NJ.

Part of CSL Ltd., Seqirus Ltd. is an investment holding British company. The company is based in Maidenhead, UK. Seqirus was founded in 2015.

Part of CSL Ltd., CSL Behring Holdings GmbH is a German company that functions as an investment holding company. The company is based in Marburg, Germany. The CEOs are Val Gene Romberg, Berthold Suesser. The company was founded in 2014.